Insulin producing islet cells


Clinical Trial - POSEIDON Study


Type 1 diabetes is an autoimmune disease that occurs when the immune system attacks and destroys the insulin-producing cells in the pancreas. The Diabetes Research Institute at the University of Miami is currently offering a research protocol for patients with type 1 diabetes within 10 years of diagnosis, and between the ages of 6 - 65 years. 

The purpose of this research study is to compare the safety and effectiveness of two oral medications (vitamin D and omega-3) that may slow-down or stop the progression of the autoimmune process and preserve your insulin-producing cells. 

If you are interested in participating in this clinical trial, please download the POSEIDON study application form, complete it, and fax it to 305-243-1058. For more information, please contact the DRI Clinical Program at 305-243-5321.  

Download form


Learn more > Watch video and read press release

Keep up with our progress toward a cure & more

Be a DRI Insider - Get News!